Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Healthcare Services Group share price today

Healthcare Services Group, Inc. · HCSG · Healthcare · Medical Care Facilities · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Healthcare Services Group share price: $26.54 at the close on 4 November 2026, +53.8% in a year.

Turning aroundBusiness trend from the last 12 quarters
$26.54Price +53.8% in a year
17.8×P/E lower than 74% of the last 1 year
$480 MRevenue (Sep 2026) +3.3% on a year ago
$24.9 MProfit (Sep 2026) −42.1% on a year ago
6.7%Operating margin −3.2 points on a year ago
12%ROE FY25
24.8%ROIC against a 9.3% cost of capital: +15.5 points

Healthcare Services Group, Inc.'s P/E is near the low end of its own history, higher than only 26% of past readings, and its quarterly results are still getting worse.

The main question: the P/E is near the low end of its own history, higher than only 26% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn.

The price has been between phases, and the P/E is lower than 74% of its own last 1 year. Over the last four quarters, results have been deteriorating, with profit −42.1% on a year earlier, and 160% of the last 3 years' profit came in as cash. What will decide it: whether results start to improve.

What is the Healthcare Services Group share price today?

Healthcare Services Group, Inc.'s share price was $26.54 at the close on 4 November 2026. That is 23.4% above its average price over the last 200 trading days. In the last 52 weeks it traded between $17 and $27, and at that close it was at the high of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 3 weeks in a row.

Nov 2026: $26.54, 23.4% above its 200-day average.

  • Price $26.54
  • 50-day avg $22.16
  • 200-day avg $21.51
Nov 2026: $26.54, 23.4% above its 200-day average.
WeekPrice50-day avg200-day avg
11 Jul 2025$13.53––
18 Jul 2025$12.69––
25 Jul 2025$13.25––
1 Aug 2025$13.07––
8 Aug 2025$14.39––
15 Aug 2025$15.02––
22 Aug 2025$15.78––
29 Aug 2025$15.61––
5 Sep 2025$15.83––
12 Sep 2025$16.02––
19 Sep 2025$15.83$14.68–
26 Sep 2025$16.36$14.99–
3 Oct 2025$16.30$15.30–
10 Oct 2025$15.18$15.56–
17 Oct 2025$16.35$15.81–
24 Oct 2025$18.49$16.11–
31 Oct 2025$17.87$16.44–
7 Nov 2025$17.26$16.66–
14 Nov 2025$17.35$16.84–
21 Nov 2025$17.97$16.96–
28 Nov 2025$18.78$17.20–
5 Dec 2025$18.88$17.47–
12 Dec 2025$19.37$17.70–
19 Dec 2025$19.54$18.02–
26 Dec 2025$19.63$18.32–
2 Jan 2026$17.35$18.53–
9 Jan 2026$19.31$18.54–
16 Jan 2026$19.09$18.64–
23 Jan 2026$18.91$18.75–
30 Jan 2026$18.82$18.88–
6 Feb 2026$19.40$19.05–
13 Feb 2026$21.59$19.23–
20 Feb 2026$20.64$19.38–
27 Feb 2026$21.77$19.62–
6 Mar 2026$20.65$19.82–
13 Mar 2026$19.54$19.84–
20 Mar 2026$18.97$19.94–
27 Mar 2026$18.49$19.95–
2 Apr 2026$18.35$19.89–
10 Apr 2026$19.49$19.92–
17 Apr 2026$19.17$19.92–
24 Apr 2026$22.42$20.05$17.75
1 May 2026$21.30$20.11$17.96
8 May 2026$23.06$20.19$18.18
15 May 2026$21.25$20.21$18.39
22 May 2026$20.43$20.27$18.57
29 May 2026$20.60$20.34$18.69
5 Jun 2026$20.37$20.42$18.82
12 Jun 2026$22.38$20.71$18.97
18 Jun 2026$22.94$21.01$19.10
26 Jun 2026$24.31$21.42$19.29
2 Jul 2026$25.15$21.88$19.46
10 Jul 2026$23.79$22.09$19.67
17 Jul 2026$25.31$22.41$19.88
24 Jul 2026$22.74$22.54$20.06
31 Jul 2026$23.30$22.73$20.25
7 Aug 2026$22.23$22.96$20.41
14 Aug 2026$21.59$23.05$20.48
21 Aug 2026$22.77$23.22$20.58
28 Aug 2026$22.44$23.27$20.71
4 Sep 2026$21.82$23.15$20.82
11 Sep 2026$21.98$22.93$20.91
18 Sep 2026$21.47$22.66$20.98
25 Sep 2026$21.05$22.36$21.05
2 Oct 2026$20.87$22.01$21.09
9 Oct 2026$20.59$21.78$21.13
16 Oct 2026$21.13$21.59$21.16
23 Oct 2026$25.30$21.74$21.27
30 Oct 2026$24.52$21.97$21.40
4 Nov 2026$26.54$22.16$21.51
Weekly closing price ($) with its 50-day and 200-day averages. 1-year window.

Week by week since 2025: did it beat the S&P 500 over the past 13 weeks?

Ahead in 43 of 57 weeks

Week by week since 2025: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
11 Jul 2025no S&P 500 reading
18 Jul 2025no S&P 500 reading
25 Jul 2025no S&P 500 reading
1 Aug 2025no S&P 500 reading
8 Aug 2025no S&P 500 reading
15 Aug 2025no S&P 500 reading
22 Aug 2025no S&P 500 reading
29 Aug 2025no S&P 500 reading
5 Sep 2025no S&P 500 reading
12 Sep 2025no S&P 500 reading
19 Sep 2025no S&P 500 reading
26 Sep 2025no S&P 500 reading
3 Oct 2025no S&P 500 reading
10 Oct 2025+7.5%
17 Oct 2025+23.0%
24 Oct 2025+33.2%
31 Oct 2025+27.0%
7 Nov 2025+14.6%
14 Nov 2025+11.1%
21 Nov 2025+11.8%
28 Nov 2025+14.4%
5 Dec 2025+13.3%
12 Dec 2025+17.2%
19 Dec 2025+20.9%
26 Dec 2025+15.7%
2 Jan 2026+4.4%
9 Jan 2026+20.9%
16 Jan 2026+12.7%
23 Jan 2026+0.5%
30 Jan 2026+3.9%
6 Feb 2026+9.5%
13 Feb 2026+23.0%
20 Feb 2026+10.2%
27 Feb 2026+15.5%
6 Mar 2026+11.3%
13 Mar 2026+3.7%
20 Mar 2026+1.8%
27 Mar 2026+2.3%
2 Apr 2026+9.8%
10 Apr 2026+3.0%
17 Apr 2026−2.3%
24 Apr 2026+15.0%
1 May 2026+9.0%
8 May 2026+12.1%
15 May 2026−10.0%
22 May 2026−9.2%
29 May 2026−15.7%
5 Jun 2026−11.0%
12 Jun 2026+2.5%
18 Jun 2026+5.8%
26 Jun 2026+16.5%
2 Jul 2026+23.5%
10 Jul 2026+11.0%
17 Jul 2026+27.4%
24 Jul 2026−2.1%
31 Jul 2026+5.7%
7 Aug 2026−8.4%
14 Aug 2026−3.4%
21 Aug 2026+8.8%
28 Aug 2026+7.2%
4 Sep 2026+2.7%
11 Sep 2026−4.8%
18 Sep 2026−8.4%
25 Sep 2026−19.2%
2 Oct 2026−20.4%
9 Oct 2026−16.6%
16 Oct 2026−19.2%
23 Oct 2026+8.4%
30 Oct 2026+4.1%
4 Nov 2026+20.2%
Each bar is one week, from 2025 to now (57 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 1 year the share price moved +96% while the S&P 500 moved +23%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Healthcare Services Group pay?

Healthcare Services Group, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.

Which stock lists is Healthcare Services Group on?

Healthcare Services Group is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Healthcare Services Group profitable?

Healthcare Services Group, Inc. earned $24.9 M of net profit in the Sep 2026 quarter, −42.1% on the same quarter a year earlier. Full-year FY25 profit was $59.1 M. Over 4 years profit has grown 5.0% a year on average. That is 5.2% of the quarter's revenue. The same quarter a year earlier earned $43.0 M.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

2 of the last 12 reported quarters were loss-making.

For the full year, FY25 profit was $59.1 M (+49.6% on the year before).

FY25 profit $59.1 M (+49.6% on the year before), 5.0% a year over 4 years

  • Net profit $59.1 M
FY25 profit $59.1 M (+49.6% on the year before), 5.0% a year over 4 years
QuarterNet profit
FY21$48.5 M
FY22$34.2 M
FY23$38.4 M
FY24$39.5 M
FY25$59.1 M

Growth on a year earlier

  • Growth on a year earlier 49.6%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−29.5%
FY2312.1%
FY242.8%
FY2549.6%
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Sep 2026: $24.9 M (−42.1% on a year earlier)

  • Net profit (quarterly) $24.9 M
Sep 2026: $24.9 M (−42.1% on a year earlier)
QuarterNet profit (quarterly)
Dec 2023$23.5 M
Mar 2024$15.3 M
Jun 2024−$1.8 M
Sep 2024$14.0 M
Dec 2024$11.9 M
Mar 2025$17.2 M
Jun 2025−$32.4 M
Sep 2025$43.0 M
Dec 2025$31.2 M
Mar 2026$26.1 M
Jun 2026$22.7 M
Sep 2026$24.9 M

Growth on a year earlier

  • Growth on a year earlier −42.1%
Growth on a year earlier
QuarterGrowth on a year earlier
Dec 202349%
Mar 202431.2%
Jun 2024−121.7%
Sep 2024–
Dec 2024−49.3%
Mar 202512.5%
Jun 2025–
Sep 2025206.2%
Dec 2025162.1%
Mar 202651.3%
Jun 2026–
Sep 2026−42.1%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +3.3% on a year earlier and the margin moved −3.2 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed +57.1% and revenue +4.0%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit.

How much revenue does Healthcare Services Group make, and is it growing?

Healthcare Services Group, Inc. reported $480 M of revenue in the Sep 2026 quarter, +3.3% on the same quarter a year earlier. That is the 11th quarter in a row with growth on the year before. Over 4 years it has grown 2.8% a year on average. The last full year, FY25, came in at $1.8 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $1.9 B.

FY25 revenue was $1.8 B, +7.1% on the year before.

FY25 revenue $1.8 B (+7.1% on the year before), 2.8% a year over 4 years

  • Revenue $1.8 B
FY25 revenue $1.8 B (+7.1% on the year before), 2.8% a year over 4 years
QuarterRevenue
FY21$1.6 B
FY22$1.7 B
FY23$1.7 B
FY24$1.7 B
FY25$1.8 B

Growth on a year earlier

  • Growth on a year earlier 7.1%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY222.9%
FY23−1.1%
FY242.7%
FY257.1%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Sep 2026: $480 M (+3.3% on a year earlier), the 11th quarter in a row of growth

  • Revenue (quarterly) $480 M
Sep 2026: $480 M (+3.3% on a year earlier), the 11th quarter in a row of growth
QuarterRevenue (quarterly)
Dec 2023$424 M
Mar 2024$423 M
Jun 2024$426 M
Sep 2024$428 M
Dec 2024$438 M
Mar 2025$448 M
Jun 2025$458 M
Sep 2025$464 M
Dec 2025$467 M
Mar 2026$463 M
Jun 2026$471 M
Sep 2026$480 M

Growth on a year earlier

  • Growth on a year earlier 3.3%
Growth on a year earlier
QuarterGrowth on a year earlier
Dec 20230%
Mar 20241.5%
Jun 20241.8%
Sep 20244.1%
Dec 20243.3%
Mar 20255.7%
Jun 20257.6%
Sep 20258.5%
Dec 20256.6%
Mar 20263.4%
Jun 20262.7%
Sep 20263.3%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +4.0% on average, against 2.8% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +4.0%, against +5.1% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +163.9%, against +43.3% a year (accelerating).

How much of every $100 of sales does Healthcare Services Group keep?

Healthcare Services Group, Inc.'s operating margin was 6.7% in the Sep 2026 quarter, 3.2 percentage points lower than the same quarter a year ago. Across 5 years it has been between 2.6% and 3.5%. The latest quarter is above every full year in that period.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −3.2 percentage points on the year while gross margin changed −4.0 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

FY25: 2.6%, within a range of 2.6% to 3.5% over 5 years

  • Operating margin 2.6%
FY25: 2.6%, within a range of 2.6% to 3.5% over 5 years
QuarterOperating margin
FY213.5%
FY223.1%
FY232.9%
FY242.6%
FY252.6%

Change on the year before (points)

  • Change on the year before (points) 0.0 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−0.4 pts
FY23−0.2 pts
FY24−0.3 pts
FY250.0 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Sep 2026: operating margin 6.7% (−3.2 points on a year earlier)

  • Operating margin 6.7%
Sep 2026: operating margin 6.7% (−3.2 points on a year earlier)
QuarterOperating margin
Dec 20236.7%
Mar 20244.2%
Jun 2024−0.7%
Sep 20243.9%
Dec 20243.1%
Mar 20255.1%
Jun 2025−10.1%
Sep 20259.9%
Dec 20255.5%
Mar 20267.3%
Jun 20264.7%
Sep 20266.7%

Change on a year earlier (points)

  • Change on a year earlier (points) −3.2 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Dec 2023+2.7 pts
Mar 2024+0.7 pts
Jun 2024−2.9 pts
Sep 2024+5.0 pts
Dec 2024−3.6 pts
Mar 2025+0.9 pts
Jun 2025−9.4 pts
Sep 2025+6.0 pts
Dec 2025+2.4 pts
Mar 2026+2.2 pts
Jun 2026+14.8 pts
Sep 2026−3.2 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Healthcare Services Group's profit turning into cash?

Over the last 3 years, 160% of Healthcare Services Group, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $145 M of operating cash against $59.1 M of profit. After $5.8 M of spending on assets, $139 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $145 M against profit $59.1 M; 160% of 3 years' profit came in as cash

  • Operating cash $145 M
  • Net profit $59.1 M
  • Free cash $139 M
FY25: operating cash $145 M against profit $59.1 M; 160% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$37.1 M$48.5 M$31.4 M
FY22−$8.2 M$34.2 M−$13.4 M
FY23$43.5 M$38.4 M$38.1 M
FY24$30.8 M$39.5 M$24.5 M
FY25$145 M$59.1 M$139 M
Operating cash flow and net profit each year, $ M. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Sep 2026: operating cash $30.2 M = 121% of the quarter's profit

  • Operating cash (quarterly) $30.2 M
Sep 2026: operating cash $30.2 M = 121% of the quarter's profit
QuarterOperating cash (quarterly)
Dec 2023$49.4 M
Mar 2024−$26.0 M
Jun 2024$16.3 M
Sep 2024$4.3 M
Dec 2024$36.2 M
Mar 2025$27.5 M
Jun 2025$28.8 M
Sep 2025$71.3 M
Dec 2025$17.4 M
Mar 2026$43.7 M
Jun 2026$21.9 M
Sep 2026$30.2 M

Operating cash as % of profit

  • Operating cash as % of profit 121%
Operating cash as % of profit
QuarterOperating cash as % of profit
Dec 2023210%
Mar 2024−170%
Jun 2024–
Sep 202431%
Dec 2024304%
Mar 2025160%
Jun 2025–
Sep 2025166%
Dec 202556%
Mar 2026168%
Jun 202696%
Sep 2026121%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Healthcare Services Group's cash go?

Healthcare Services Group, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $17.6 M on assets over the last 3 years. Averaged over those years that is 0.3% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $17.6 M over the last 3 years.

FY25: capex $5.8 M, steady spending

  • Capex $5.8 M
FY25: capex $5.8 M, steady spending
QuarterCapex
FY21$5.7 M
FY22$5.2 M
FY23$5.4 M
FY24$6.3 M
FY25$5.8 M
Capital spending each year, $ M.

Sep 2026: capex $2.1 M in the quarter

  • Capex (quarterly) $2.1 M
Sep 2026: capex $2.1 M in the quarter
QuarterCapex (quarterly)
Dec 2023$1.4 M
Mar 2024$2.2 M
Jun 2024$1.3 M
Sep 2024$1.4 M
Dec 2024$1.4 M
Mar 2025$1.7 M
Jun 2025$1.4 M
Sep 2025$1.3 M
Dec 2025$1.4 M
Mar 2026$1.4 M
Jun 2026$1.6 M
Sep 2026$2.1 M

Free cash

  • Free cash $28.1 M
Free cash
QuarterFree cash
Dec 2023$48.0 M
Mar 2024−$28.2 M
Jun 2024$15.0 M
Sep 2024$2.9 M
Dec 2024$34.8 M
Mar 2025$25.8 M
Jun 2025$27.4 M
Sep 2025$70.0 M
Dec 2025$16.0 M
Mar 2026$42.3 M
Jun 2026$20.2 M
Sep 2026$28.1 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Healthcare Services Group's P/E ratio, and how does it compare with its own history?

Healthcare Services Group, Inc.'s P/E is 17.8×, near the low end of its own history: it has been lower only 26% of the time. Its usual P/E (the middle reading) is 23.6×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 17.8× against a usual 23.6×: near the low end of its own history: it has been lower only 26% of the time

  • P/E 17.9×
  • Median 23.6×
P/E 17.8× against a usual 23.6×: near the low end of its own history: it has been lower only 26% of the time
WeekP/EMedian
11 Jul 202570.9×23.6×
18 Jul 202570.9×23.6×
25 Jul 202570.9×23.6×
1 Aug 202570.9×23.6×
8 Aug 202570.9×23.6×
15 Aug 202570.9×23.6×
22 Aug 202570.9×23.6×
29 Aug 202570.9×23.6×
5 Sep 202570.9×23.6×
12 Sep 202570.9×23.6×
19 Sep 202570.9×23.6×
26 Sep 202570.9×23.6×
3 Oct 202530.3×23.6×
10 Oct 202528.2×23.6×
17 Oct 202530.4×23.6×
24 Oct 202534.4×23.6×
31 Oct 202533.2×23.6×
7 Nov 202532.1×23.6×
14 Nov 202532.3×23.6×
21 Nov 202533.4×23.6×
28 Nov 202534.9×23.6×
5 Dec 202535.1×23.6×
12 Dec 202536.0×23.6×
19 Dec 202536.3×23.6×
26 Dec 202536.5×23.6×
2 Jan 202621.3×23.6×
9 Jan 202623.8×23.6×
16 Jan 202623.5×23.6×
23 Jan 202623.3×23.6×
30 Jan 202623.1×23.6×
6 Feb 202623.9×23.6×
13 Feb 202626.6×23.6×
20 Feb 202625.4×23.6×
27 Feb 202626.8×23.6×
6 Mar 202625.4×23.6×
13 Mar 202624.0×23.6×
20 Mar 202623.3×23.6×
27 Mar 202622.7×23.6×
2 Apr 202619.3×23.6×
10 Apr 202620.4×23.6×
17 Apr 202620.1×23.6×
24 Apr 202623.5×23.6×
1 May 202622.4×23.6×
8 May 202624.2×23.6×
15 May 202622.3×23.6×
22 May 202621.4×23.6×
29 May 202621.6×23.6×
5 Jun 202621.4×23.6×
12 Jun 202623.5×23.6×
18 Jun 202624.1×23.6×
26 Jun 202625.5×23.6×
2 Jul 202614.7×23.6×
10 Jul 202613.9×23.6×
17 Jul 202614.8×23.6×
24 Jul 202613.3×23.6×
31 Jul 202613.6×23.6×
7 Aug 202612.9×23.6×
14 Aug 202612.6×23.6×
21 Aug 202613.3×23.6×
28 Aug 202613.1×23.6×
4 Sep 202612.7×23.6×
11 Sep 202612.8×23.6×
18 Sep 202612.5×23.6×
25 Sep 202612.3×23.6×
2 Oct 202614.0×23.6×
9 Oct 202613.9×23.6×
16 Oct 202614.2×23.6×
23 Oct 202617.0×23.6×
30 Oct 202616.5×23.6×
4 Nov 202617.9×23.6×

Earnings per share, 12 months

  • Earnings per share, 12 months $1.49
Earnings per share, 12 months
WeekEarnings per share, 12 months
11 Jul 2025–
18 Jul 2025–
25 Jul 2025–
1 Aug 2025–
8 Aug 2025–
15 Aug 2025–
22 Aug 2025–
29 Aug 2025–
5 Sep 2025–
12 Sep 2025–
19 Sep 2025–
26 Sep 2025$0.14
3 Oct 2025$0.14
10 Oct 2025$0.14
17 Oct 2025$0.14
24 Oct 2025$0.14
31 Oct 2025$0.14
7 Nov 2025$0.14
14 Nov 2025$0.14
21 Nov 2025$0.14
28 Nov 2025$0.14
5 Dec 2025$0.14
12 Dec 2025$0.14
19 Dec 2025$0.14
26 Dec 2025$0.54
2 Jan 2026$0.54
9 Jan 2026$0.54
16 Jan 2026$0.54
23 Jan 2026$0.54
30 Jan 2026$0.54
6 Feb 2026$0.54
13 Feb 2026$0.54
20 Feb 2026$0.54
27 Feb 2026$0.54
6 Mar 2026$0.54
13 Mar 2026$0.54
20 Mar 2026$0.54
27 Mar 2026$0.81
2 Apr 2026$0.81
10 Apr 2026$0.81
17 Apr 2026$0.81
24 Apr 2026$0.81
1 May 2026$0.81
8 May 2026$0.81
15 May 2026$0.81
22 May 2026$0.81
29 May 2026$0.81
5 Jun 2026$0.81
12 Jun 2026$0.81
18 Jun 2026$0.81
26 Jun 2026$0.95
2 Jul 2026$0.95
10 Jul 2026$0.95
17 Jul 2026$0.95
24 Jul 2026$0.95
31 Jul 2026$0.95
7 Aug 2026$0.95
14 Aug 2026$0.95
21 Aug 2026$0.95
28 Aug 2026$0.95
4 Sep 2026$0.95
11 Sep 2026$0.95
18 Sep 2026$0.95
25 Sep 2026$1.72
2 Oct 2026$1.72
9 Oct 2026$1.72
16 Oct 2026$1.72
23 Oct 2026$1.72
30 Oct 2026$1.72
4 Nov 2026$1.49
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 1 year of history; short peaks above 71× are drawn at the top edge.

PEG 1.44 at the Sep 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 1.44×
  • PEG = 1.0 1.00×
PEG 1.44 at the Sep 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Sep 20211.85×1.00×
Dec 20211.99×1.00×
Mar 20223.17×1.00×
Jun 20222.14×1.00×
Sep 20221.37×1.00×
Dec 20222.29×1.00×
Mar 20232.51×1.00×
Jun 20232.28×1.00×
Sep 20231.64×1.00×
Dec 20231.70×1.00×
Mar 20241.76×1.00×
Jun 20241.53×1.00×
Sep 20241.48×1.00×
Dec 20241.44×1.00×
Mar 20251.44×1.00×
Jun 20251.44×1.00×
Sep 20251.44×1.00×
Dec 20251.44×1.00×
Mar 20261.44×1.00×
Jun 20261.44×1.00×
Sep 20261.44×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 21 quarters.
17.8×P/E · lower than 74% of its last 1 year
0.87PEG · today, derived from 3-year earnings growth

Why the multiple is where it is: over the past year earnings per share moved +52.8% while the price moved +53.8%. The price did better than earnings, which pushed the multiple up within its own range.

In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.

Is the Healthcare Services Group business getting better or worse?

Healthcare Services Group, Inc.'s business is turning around. Profit growth has swung from −22.2% at its low to +163.9%, rising from a low 4 quarters ago, with ROCE rising at 18.2%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +7.1% in FY25, profit +49.6%

  • Revenue growth 7.1%
Growth year by year: revenue +7.1% in FY25, profit +49.6%
QuarterRevenue growth
FY21–
FY222.9%
FY23−1.1%
FY242.7%
FY257.1%

Profit growth, EPS growth

  • Profit growth 49.6%
  • EPS growth 52.8%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22−29.5%−29.1%
FY2312.1%12.3%
FY242.8%2.6%
FY2549.6%52.8%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue stabilising, profit accelerating

  • Revenue 4%
Three growth lines over twelve quarters: revenue stabilising, profit accelerating
QuarterRevenue
Dec 2023−1.1%
Mar 2024−0.2%
Jun 20240.6%
Sep 20241.8%
Dec 20242.7%
Mar 20253.7%
Jun 20255.2%
Sep 20256.3%
Dec 20257.1%
Mar 20266.5%
Jun 20265.2%
Sep 20264%

Profit, EPS

  • Profit 163.9%
  • EPS 176.4%
Profit, EPS
QuarterProfitEPS
Dec 202312.1%13.4%
Mar 202421.5%22.7%
Jun 2024−11.2%−10.3%
Sep 202466.6%70%
Dec 20242.8%3.4%
Mar 2025−1.5%−1.7%
Jun 2025−66.2%−68.1%
Sep 2025−22.2%−22.2%
Dec 202549.6%52.7%
Mar 202664%71.5%
Jun 2026300%300%
Sep 2026163.9%176.4%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. Extreme jumps from a tiny base are drawn at the edge (▲). A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 18.2%
ROCE: the return line, worked out each quarter
QuarterROCE
Dec 2023–
Mar 2024–
Jun 2024–
Sep 2024–
Dec 20247.6%
Mar 20258.3%
Jun 20251.2%
Sep 20256%
Dec 20257.9%
Mar 20269.5%
Jun 202620.9%
Sep 202618.2%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Steady highRevenue growth · latest +4.0%, range −1.1% to +7.1%
RisingProfit growth · latest +163.9%, range −66.2% to +1,037.2%
RisingEPS growth · latest +176.4%, range −68.1% to +1,146.8%
RisingROCE · latest 18.2%, range 1.2% to 20.9%

Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+7.1%+2.8%——
Profit+49.6%+19.9%——
EPS+52.8%+20.8%——
Stock price+53.8%———
+3.3%Revenue growth (Sep 2026) · latest quarter against a year ago
−42.1%Profit growth (Sep 2026) · latest quarter against a year ago
2.8%Revenue, 4 years · yearly growth over the long run

How much does Healthcare Services Group earn on its capital?

Healthcare Services Group, Inc. earned a ROE of 12% in FY25. That is up from a low of 8% in FY24. Its return on capital used (ROIC) is 15.5 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 3.2% net margin and 2.31× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 3.2% net margin × 2.31× asset turnover × 1.56× leverage (assets divided by equity) ≈ 11.5% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 24.8% − 9.3% = +15.5 percentage points. The 9.3% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value.

The 24.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 11.0%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

FY25: ROE 12%, the climb back from FY24's 8%

  • ROE 11.6%
  • ROIC (annual) 11%
  • Cost of capital 9.3%
FY25: ROE 12%, the climb back from FY24's 8%
QuarterROEROIC (annual)Cost of capital
FY2110.7%16.4%9.3%
FY228.2%13.1%9.3%
FY238.4%10.1%9.3%
FY247.9%8.8%9.3%
FY2511.6%11%9.3%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 9.3% cost of capital used on this page.

Sep 2026: ROIC 4.5% (last 12 months) against a 9.3% cost of capital

  • ROIC (12 months) 4.5%
  • ROE (12 months) 17.6%
  • Cost of capital 9.3%
Sep 2026: ROIC 4.5% (last 12 months) against a 9.3% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Dec 2023−1.2%−4.5%9.3%
Mar 20245.6%20.9%9.3%
Jun 20243.2%13.2%9.3%
Sep 2024−0.7%−1.5%9.3%
Dec 20242.9%11.7%9.3%
Mar 20252.7%9.6%9.3%
Jun 20254%13.6%9.3%
Sep 2025−11.9%−26.1%9.3%
Dec 202510%35.3%9.3%
Mar 20267.5%24.8%9.3%
Jun 20267.2%20.4%9.3%
Sep 20264.5%17.6%9.3%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does Healthcare Services Group have too much debt?

Healthcare Services Group, Inc. has total debt of $18.0 M against shareholder equity of $531 M as of Sep 2026, so its debt is 0.03× its equity, which is very little. Year by year, that ratio went from 0.04 in FY21 to 0.03 in FY25. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $15.0 M, 0.03× equity

  • Total debt $15.0 M
FY25: debt $15.0 M, 0.03× equity
QuarterTotal debt
FY21$17.8 M
FY22$38.4 M
FY23$43.6 M
FY24$16.5 M
FY25$15.0 M

Debt-to-equity

  • Debt-to-equity 0.03×
Debt-to-equity
QuarterDebt-to-equity
FY210.04×
FY220.09×
FY230.10×
FY240.03×
FY250.03×
Top: total debt each year, $ M. Below: debt-to-equity, ×. 5-year window.

Sep 2026: debt $18.0 M, debt-to-equity 0.03

  • Total debt (quarterly) $18.0 M
Sep 2026: debt $18.0 M, debt-to-equity 0.03
QuarterTotal debt (quarterly)
Dec 2023$43.6 M
Mar 2024$58.2 M
Jun 2024$48.6 M
Sep 2024$42.1 M
Dec 2024$16.5 M
Mar 2025$16.5 M
Jun 2025$15.4 M
Sep 2025$13.9 M
Dec 2025$15.0 M
Mar 2026$14.7 M
Jun 2026$17.7 M
Sep 2026$18.0 M

Debt-to-equity

  • Debt-to-equity 0.03×
Debt-to-equity
QuarterDebt-to-equity
Dec 20230.10×
Mar 20240.12×
Jun 20240.10×
Sep 20240.09×
Dec 20240.03×
Mar 20250.03×
Jun 20250.03×
Sep 20250.03×
Dec 20250.03×
Mar 20260.03×
Jun 20260.03×
Sep 20260.03×
Top: total debt each quarter, $ M. Below: debt-to-equity, ×. Last 12 quarters.

What is the Healthcare Services Group shareholding pattern?

4.1% of Healthcare Services Group, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 3.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

4.1%Short interest · of the tradable float
3.6Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Healthcare Services Group from balance-sheet trouble?

For Healthcare Services Group, Inc., the Z-score is 6.44. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 6.44 is well clear of the danger zone, so the balance sheet is not the risk here.

How does Healthcare Services Group rank in its industry?

60.3 out of 100, rank 6 of 30 in Medical Care Facilities, with 85% of the evidence available.

Healthcare Services Group, Inc. scores 60.3 out of 100 against the 30 companies it is compared with in Medical Care Facilities, ranking 6. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 20.4 + 14.6 + 14.3 + 11 = 60.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Healthcare Services Group compared with?

Healthcare Services Group ranks 6 of 30 Medical Care Facilities companies on the 4-Factor Sector Score, with 60.3 out of 100.

  1. 1Concentra Group Holdings Parent, Inc.CON · leader · Most evidence points up · 81% evidence71.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.0/35 · Revenue 14% · Profit 32.6% · Operating margin change 2.3 points · 83% evidenceCapital efficiency 16.6/25 · ROCE 14.5% · Operating margin 19.3% · 76% evidenceValuation 12.8/20 · P/E 19.5× · PEG 0.65 · 65% evidenceRelative strength 18.5/20 · Lead over its industry 20.3% · Lead over S&P 500 51% · 1 year 125.2% · 100% evidence · 12 of 12 weeks aheadExact sum: 24 + 16.6 + 12.8 + 18.5 = 71.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2Nutex Health Inc.NUTX · leader · Most evidence points up · 64% evidence66.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.5/35 · Revenue 6.8% · Profit 100% · Operating margin change 44 points · 62% evidenceCapital efficiency 18.7/25 · ROCE 56.8% · Operating margin 57.8% · 76% evidenceValuation 10.8/20 · P/E 6.5× · PEG — · 15% evidenceRelative strength 14.6/20 · Lead over its industry 1% · Lead over S&P 500 28% · 1 year 79% · 100% evidence · 12 of 12 weeks aheadExact sum: 22.5 + 18.7 + 10.8 + 14.6 = 66.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Tenet Healthcare CorporationTHC · leader · Most evidence points up · 81% evidence65.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.8/35 · Revenue 5.4% · Profit 32.4% · Operating margin change 2.1 points · 83% evidenceCapital efficiency 17.1/25 · ROCE 15% · Operating margin 18.2% · 76% evidenceValuation 15.2/20 · P/E 7.2× · PEG 0.35 · 65% evidenceRelative strength 12.6/20 · Lead over its industry -1.3% · Lead over S&P 500 25.8% · 1 year 42.4% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.8 + 17.1 + 15.2 + 12.6 = 65.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4AMN Healthcare Services, Inc.AMN · breaking out · Evidence leans up · 64% evidence64.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.4/35 · Revenue 23.9% · Profit — · Operating margin change 3.4 points · 62% evidenceCapital efficiency 9.1/25 · ROCE 10.1% · Operating margin 4% · 76% evidenceValuation 10.3/20 · P/E 12× · PEG — · 15% evidenceRelative strength 19.3/20 · Lead over its industry 36.3% · Lead over S&P 500 69.4% · 1 year 167.2% · 100% evidence · 9 of 12 weeks aheadExact sum: 25.4 + 9.1 + 10.3 + 19.3 = 64.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5Pediatrix Medical Group, Inc.MD · turning · Evidence leans up · 81% evidence61.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.1/35 · Revenue 0.6% · Profit 61.5% · Operating margin change -0.2 points · 83% evidenceCapital efficiency 14.6/25 · ROCE 14.8% · Operating margin 13.4% · 76% evidenceValuation 12.8/20 · P/E 11.6× · PEG 0.8 · 65% evidenceRelative strength 15.4/20 · Lead over its industry 1.6% · Lead over S&P 500 29.5% · 1 year 49.6% · 100% evidence · 8 of 12 weeks aheadExact sum: 19.1 + 14.6 + 12.8 + 15.4 = 61.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Healthcare Services Group, Inc. this pageHCSG · turning · Evidence leans up · 85% evidence60.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.4/35 · Revenue 4% · Profit 100% · Operating margin change -3.2 points · 95% evidenceCapital efficiency 14.6/25 · ROCE 17.7% · Operating margin 6.7% · 76% evidenceValuation 14.3/20 · P/E 13.4× · PEG 0.43 · 65% evidenceRelative strength 11.0/20 · Lead over its industry -7.3% · Lead over S&P 500 18.3% · 1 year 53.8% · 100% evidence · 4 of 12 weeks aheadExact sum: 20.4 + 14.6 + 14.3 + 11 = 60.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Aveanna Healthcare Holdings Inc.AVAH · leader · Too little evidence to rank firmly · 58% evidence60.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 15.4/35 · Revenue — · Profit — · Operating margin change 1.6 points · 45% evidenceCapital efficiency 15.4/25 · ROCE 17.7% · Operating margin 12.6% · 76% evidenceValuation 10.6/20 · P/E 7.2× · PEG — · 15% evidenceRelative strength 18.6/20 · Lead over its industry 14.8% · Lead over S&P 500 45.2% · 1 year 62.6% · 100% evidence · 12 of 12 weeks aheadExact sum: 15.4 + 15.4 + 10.6 + 18.6 = 60 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  8. 8Encompass Health CorporationEHC · leader · Evidence leans up · 81% evidence59.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.5/35 · Revenue 9.5% · Profit 20.2% · Operating margin change 0.3 points · 83% evidenceCapital efficiency 18.1/25 · ROCE 17% · Operating margin 18.1% · 76% evidenceValuation 12.2/20 · P/E 16.2× · PEG 0.8 · 65% evidenceRelative strength 11.6/20 · Lead over its industry -6.7% · Lead over S&P 500 19.5% · 1 year 22.3% · 100% evidence · 12 of 12 weeks aheadExact sum: 17.5 + 18.1 + 12.2 + 11.6 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9HCA Healthcare, Inc.HCA · breaking out · Evidence leans up · 81% evidence58.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 15.4/35 · Revenue 7.3% · Profit 14.6% · Operating margin change -0.7 points · 83% evidenceCapital efficiency 19.9/25 · ROCE 26.3% · Operating margin 15.2% · 76% evidenceValuation 14.2/20 · P/E 12.6× · PEG 0.49 · 65% evidenceRelative strength 8.8/20 · Lead over its industry -18.7% · Lead over S&P 500 5.4% · 1 year 7.2% · 100% evidence · 10 of 12 weeks aheadExact sum: 15.4 + 19.9 + 14.2 + 8.8 = 58.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far.
  10. 10Universal Health Services, Inc.UHS · breaking out · Evidence leans up · 81% evidence57.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.8/35 · Revenue 10% · Profit 21% · Operating margin change -0.6 points · 83% evidenceCapital efficiency 16.4/25 · ROCE 16.3% · Operating margin 11.1% · 76% evidenceValuation 15.9/20 · P/E 5.9× · PEG 0.2 · 65% evidenceRelative strength 6.6/20 · Lead over its industry -24.5% · Lead over S&P 500 -1.6% · 1 year -14.3% · 100% evidence · 11 of 12 weeks aheadExact sum: 18.8 + 16.4 + 15.9 + 6.6 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11LifeStance Health Group, Inc.LFST · turning · Evidence leans up · 64% evidence56.1out of 100GrowthCapitalValuationRelative
  12. 12Addus HomeCare CorporationADUS · turning · Evidence leans up · 81% evidence55.6out of 100GrowthCapitalValuationRelative
  13. 13PACS Group, Inc.PACS · turning · Evidence leans up · 71% evidence53.5out of 100GrowthCapitalValuationRelative
  14. 14National HealthCare CorporationNHC · quiet · Evidence leans up · 81% evidence53.1out of 100GrowthCapitalValuationRelative
  15. 15Fresenius Medical Care AGFMS · basing · Evidence leans up · 81% evidence50.7out of 100GrowthCapitalValuationRelative
  16. 16Guardian Pharmacy Services, Inc.GRDN · quiet · Evidence leans down · 64% evidence49.3out of 100GrowthCapitalValuationRelative
  17. 17Chemed CorporationCHE · turning · Evidence leans down · 81% evidence48.5out of 100GrowthCapitalValuationRelative
  18. 18Astrana Health, Inc.ASTH · turning · Evidence leans down · 81% evidence48.1out of 100GrowthCapitalValuationRelative
  19. 19Surgery Partners, Inc.SGRY · turning · Evidence leans down · 64% evidence48.1out of 100GrowthCapitalValuationRelative
  20. 20DaVita Inc.DVA · turning · Evidence leans down · 81% evidence47.9out of 100GrowthCapitalValuationRelative
  21. 21The Pennant Group, Inc.PNTG · turning · Evidence leans down · 81% evidence44.1out of 100GrowthCapitalValuationRelative
  22. 22The Ensign Group, Inc.ENSG · turning · Evidence leans down · 81% evidence41.8out of 100GrowthCapitalValuationRelative
  23. 23agilon health, inc.AGL · turning · Evidence leans down · 64% evidence41.3out of 100GrowthCapitalValuationRelative
  24. 24InnovAge Holding Corp.INNV · quiet · Evidence leans down · 64% evidence39.9out of 100GrowthCapitalValuationRelative
  25. 25Acadia Healthcare Company, Inc.ACHC · turning · Evidence leans down · 71% evidence39.4out of 100GrowthCapitalValuationRelative
  26. 26Option Care Health, Inc.OPCH · breaking out · Evidence leans down · 81% evidence39.3out of 100GrowthCapitalValuationRelative
  27. 27Ardent Health, Inc.ARDT · breaking out · Evidence leans down · 71% evidence37.8out of 100GrowthCapitalValuationRelative
  28. 28Sonida Senior Living, Inc.SNDA · quiet · Evidence leans down · 64% evidence36.8out of 100GrowthCapitalValuationRelative
  29. 29Brookdale Senior Living Inc.BKD · quiet · Most evidence points down · 64% evidence32.9out of 100GrowthCapitalValuationRelative
  30. 30Select Medical Holdings CorporationSEM · Too little evidence to rank firmly · 36% evidence50.6out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Care Facilities, all 30 compared on one page.

Which companies are close to Healthcare Services Group in size?

Healthcare Services Group is the 25th largest of 38 Medical Care Facilities companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Astrana Health, Inc., AMN Healthcare Services, Inc. and Ardent Health, Inc. Just below it: Sonida Senior Living, Inc., agilon health, inc. and The Pennant Group, Inc.

Medical Care Facilities companies close in size

  1. Astrana Health, Inc. $2 billion
  2. AMN Healthcare Services, Inc. $1.8 billion
  3. Ardent Health, Inc. $1.8 billion
  4. Healthcare Services Group, Inc. $1.8 billion
  5. Sonida Senior Living, Inc. $1.8 billion
  6. agilon health, inc. $1.6 billion
  7. The Pennant Group, Inc. $1.5 billion

All 38 Medical Care Facilities companies, largest first

Companies close in size in other industries

  1. ChipMOS TECHNOLOGIES INC. $1.8 billion · Semiconductors
  2. Innovex International, Inc. $1.8 billion · Oil & Gas Equipment & Services
  3. Healthcare Services Group, Inc. $1.8 billion
  4. Diversified Healthcare Trust $1.8 billion · REIT - Healthcare Facilities
  5. ACV Auctions Inc. $1.8 billion · Auto & Truck Dealerships

What else do people ask about Healthcare Services Group?

What were Healthcare Services Group's latest quarterly results?

Healthcare Services Group, Inc. reported revenue of $480 M and net profit of $24.9 M for the Sep 2026 quarter. Revenue rose 3.3% and profit fell 42.1% compared with a year earlier. Earnings per share were $0.36.

The operating margin was 6.7%, 3.2 percentage points lower than a year earlier (as of 4 November 2026).

What is Healthcare Services Group's market cap?

Healthcare Services Group, Inc.'s market capitalisation is $1.8 B at a stock price of $26.54. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Healthcare Services Group performing?

Healthcare Services Group, Inc.'s latest readings are below. In its latest quarter, revenue rose 3.3% and profit fell 42.1% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 3 weeks running.

This describes what the data did, not a rating (as of 4 November 2026).

Will Healthcare Services Group's stock price go up?

This page does not forecast Healthcare Services Group, Inc.'s stock price. What it shows instead: the stock price is $26.54. Its P/E of 17.8× is higher than 26% of its own last 1 years.

Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Where is Healthcare Services Group in its business cycle?

Healthcare Services Group, Inc.'s FY25 operating margin was 2.6%, against a 5-year range of 2.6% to 3.5%: the low end of its own range, which is often where recoveries start. The latest quarter was 6.7%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Healthcare Services Group story?

The main question: the P/E is near the low end of its own history, higher than only 26% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Healthcare Services Group a stock worth studying right now?

What the numbers show: Healthcare Services Group, Inc.'s P/E is near the low end of its own history, higher than only 26% of past readings, and its quarterly results are still getting worse. The main open question: whether results start to improve.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.